Skip to content
10-Q

Quarterly Report

ARATANA THERAPEUTICS, INC.

0001509190-18-000050

← back to feed
Filed
Nov 2, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · Oct 29, 2018 48.62M sh
Shares Diluted Q3 2018 · Sep 30, 2018 47.49M sh
Shares Diluted Q3 2018 · Sep 30, 2018 46.13M sh
Shares Diluted Q3 2018 · Sep 30, 2017 42.45M sh
Shares Diluted Q3 2018 · Sep 30, 2017 39.82M sh
Operating Cash Flow Q3 2018 · Sep 30, 2018 −$23.77M
Operating Cash Flow Q3 2018 · Sep 30, 2017 −$38.53M
Short Term Investments Q3 2018 · Sep 30, 2018 $1.74M
Short Term Investments Q3 2018 · Dec 31, 2017 $747K
Cash And Equivalents Q3 2018 · Sep 30, 2018 $54.29M
Cash And Equivalents Q3 2018 · Dec 31, 2017 $66.87M
Stockholders Equity Q3 2018 · Sep 30, 2018 $108.4M
Stockholders Equity Q3 2018 · Dec 31, 2017 $80.13M
Current Liabilities Q3 2018 · Sep 30, 2018 $28.69M
Current Liabilities Q3 2018 · Dec 31, 2017 $35.5M
Total Liabilities Q3 2018 · Sep 30, 2018 $31.41M
Total Liabilities Q3 2018 · Dec 31, 2017 $55.06M
Current Assets Q3 2018 · Sep 30, 2018 $91.07M
Current Assets Q3 2018 · Dec 31, 2017 $85.24M
Total Assets Q3 2018 · Sep 30, 2018 $139.8M
Total Assets Q3 2018 · Dec 31, 2017 $135.19M
Eps Diluted Q3 2018 · Sep 30, 2018 $0.19
Eps Diluted Q3 2018 · Sep 30, 2018 −$0.13
Eps Diluted Q3 2018 · Sep 30, 2017 −$0.21
Eps Diluted Q3 2018 · Sep 30, 2017 −$0.80
Eps Basic Q3 2018 · Sep 30, 2018 $0.19
Eps Basic Q3 2018 · Sep 30, 2018 −$0.13
Eps Basic Q3 2018 · Sep 30, 2017 −$0.21
Eps Basic Q3 2018 · Sep 30, 2017 −$0.80
Sga Expense Q3 2018 · Sep 30, 2018 $7.01M
Sga Expense Q3 2018 · Sep 30, 2018 $21.42M
Sga Expense Q3 2018 · Sep 30, 2017 $6.91M
Sga Expense Q3 2018 · Sep 30, 2017 $21.32M
Rd Expense Q3 2018 · Sep 30, 2018 $1.51M
Rd Expense Q3 2018 · Sep 30, 2018 $5.29M
Rd Expense Q3 2018 · Sep 30, 2017 $3.22M
Rd Expense Q3 2018 · Sep 30, 2017 $11.57M
Net Income Q3 2018 · Sep 30, 2018 $8.83M
Net Income Q3 2018 · Sep 30, 2018 −$6.09M
Net Income Q3 2018 · Sep 30, 2017 −$8.92M
Net Income Q3 2018 · Sep 30, 2017 −$31.91M
Operating Income Q3 2018 · Sep 30, 2018 $9.39M
Operating Income Q3 2018 · Sep 30, 2018 −$4.17M
Operating Income Q3 2018 · Sep 30, 2017 −$8.18M
Operating Income Q3 2018 · Sep 30, 2017 −$29.61M
Cost Of Revenue Q3 2018 · Sep 30, 2018 $2.17M
Cost Of Revenue Q3 2018 · Sep 30, 2018 $4.01M
Cost Of Revenue Q3 2018 · Sep 30, 2017 $3.69M
Cost Of Revenue Q3 2018 · Sep 30, 2017 $10.48M
Revenue Q3 2018 · Sep 30, 2018 $21.56M
Revenue Q3 2018 · Sep 30, 2018 $30.51M
Revenue Q3 2018 · Sep 30, 2017 $6.16M
Revenue Q3 2018 · Sep 30, 2017 $15.12M
Capex Q3 2018 · Sep 30, 2017 $16K